ID

38879

Beskrivning

Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea; ODM derived from: https://clinicaltrials.gov/show/NCT01355718

Länk

https://clinicaltrials.gov/show/NCT01355718

Nyckelord

Versioner (1)
  1. 2019-11-11 2019-11-11 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

11 november 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Diabetes NCT01355718

Engelsk

Eligibility Diabetes NCT01355718

1 Formulär  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01355718
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
informed consent obtained before any study-related activities. (study-related activities are any procedure related to recording of data according to the protocol.)
Beskrivning

Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
patients with type 2 diabetes mellitus
Beskrivning

Diabetes Mellitus, Non-Insulin-Dependent

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
patients who are currently treated with novonorm® alone or in combination with metformin or tzd
Beskrivning

NovoNorm | Combined Modality Therapy | Metformin | Thiazolidinediones

Datatyp

boolean

Alias
UMLS CUI [1]
C0732644
UMLS CUI [2]
C0009429
UMLS CUI [3]
C0025598
UMLS CUI [4]
C1257987
age: at least 18 years old
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
patients who will be prescribed with insulin analogue in addition to current novonorm® (with/without metformin/tzd) treatment at the discretion by the physician
Beskrivning

Insulin Analog In addition to NovoNorm | Metformin | Metformin Absent | Thiazolidinediones | Thiazolidinediones Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2825028
UMLS CUI [1,2]
C0332287
UMLS CUI [1,3]
C0732644
UMLS CUI [2]
C0025598
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C1257987
UMLS CUI [5,1]
C1257987
UMLS CUI [5,2]
C0332197
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to study product(s) or related products
Beskrivning

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Pharmaceutical Preparations Related

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0013227
UMLS CUI [3,3]
C0439849
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C0439849
previous participation in this study. participation is defined as screened
Beskrivning

Study Subject Participation Status

Datatyp

boolean

Alias
UMLS CUI [1]
C2348568
patients who have been treated with insulin preparations (including insulin analogues) previously
Beskrivning

Prior Therapy Insulin preparations | Prior Therapy Insulin Analog

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0021641
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C2825028
females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice)
Beskrivning

Pregnancy | Breast Feeding | Pregnancy intended | Childbearing Potential Contraceptive methods Absent

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C0032961
UMLS CUI [3,2]
C1283828
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0700589
UMLS CUI [4,3]
C0332197
patients who are unlikely to comply with protocol requirements, e.g. uncooperative attitude, inability to return for the final visit
Beskrivning

Protocol Compliance Unlikely | Uncooperative attitude | Clinic Visit Final Unable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0750558
UMLS CUI [2]
C2188045
UMLS CUI [3,1]
C0008952
UMLS CUI [3,2]
C3853528
UMLS CUI [3,3]
C1299582
any other disease or condition that the physician feels would interfere with study participation or evaluation of results
Beskrivning

Disease Interferes with Study Subject Participation Status | Condition Interferes with Study Subject Participation Status | Disease Interferes with Evaluation Research results | Condition Interferes with Evaluation Research results

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C0012634
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C1261322
UMLS CUI [3,4]
C0683954
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C1261322
UMLS CUI [4,4]
C0683954
Tillbaka till toppen

Similar models

Eligibility Diabetes NCT01355718

1 Formulär
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01355718
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
informed consent obtained before any study-related activities. (study-related activities are any procedure related to recording of data according to the protocol.)
boolean
C0021430 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
patients with type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
NovoNorm | Combined Modality Therapy | Metformin | Thiazolidinediones
Item
patients who are currently treated with novonorm® alone or in combination with metformin or tzd
boolean
C0732644 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0025598 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
Age
Item
age: at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Insulin Analog In addition to NovoNorm | Metformin | Metformin Absent | Thiazolidinediones | Thiazolidinediones Absent
Item
patients who will be prescribed with insulin analogue in addition to current novonorm® (with/without metformin/tzd) treatment at the discretion by the physician
boolean
C2825028 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C0732644 (UMLS CUI [1,3])
C0025598 (UMLS CUI [2])
C0025598 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1257987 (UMLS CUI [4])
C1257987 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Pharmaceutical Preparations Related
Item
known or suspected allergy to study product(s) or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0013227 (UMLS CUI [3,2])
C0439849 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C0439849 (UMLS CUI [4,4])
Study Subject Participation Status
Item
previous participation in this study. participation is defined as screened
boolean
C2348568 (UMLS CUI [1])
Prior Therapy Insulin preparations | Prior Therapy Insulin Analog
Item
patients who have been treated with insulin preparations (including insulin analogues) previously
boolean
C1514463 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C2825028 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Pregnancy intended | Childbearing Potential Contraceptive methods Absent
Item
females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032961 (UMLS CUI [3,1])
C1283828 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
Protocol Compliance Unlikely | Uncooperative attitude | Clinic Visit Final Unable
Item
patients who are unlikely to comply with protocol requirements, e.g. uncooperative attitude, inability to return for the final visit
boolean
C0525058 (UMLS CUI [1,1])
C0750558 (UMLS CUI [1,2])
C2188045 (UMLS CUI [2])
C0008952 (UMLS CUI [3,1])
C3853528 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Disease Interferes with Study Subject Participation Status | Condition Interferes with Study Subject Participation Status | Disease Interferes with Evaluation Research results | Condition Interferes with Evaluation Research results
Item
any other disease or condition that the physician feels would interfere with study participation or evaluation of results
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0012634 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1261322 (UMLS CUI [3,3])
C0683954 (UMLS CUI [3,4])
C0348080 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C1261322 (UMLS CUI [4,3])
C0683954 (UMLS CUI [4,4])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial